Lineage Cell Therapeutics (LCTX) Stock: Buy, Sell, or Hold?
LCTX - Lineage Cell Therapeutics, Inc.
$1.04
0.01 (0.97%)
â˛
5d:
+9.3%
30d:
+9.76%
90d:
-6.31%
WAIT
LOW Confidence
Analysis Updated: Oct 28, 2026 12:00 AM ET
Earnings: Nov 05, 2026
6d
Get Alerted When LCTX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: LCTX is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: LCTX is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: LCTX is currently trading at $1.04, which is considered slightly high relative to its 30-day fair value range of $0.93 to $1.01.
Technical Outlook: Technically, LCTX is in a strong downtrend. The price is approaching resistance at $1.04. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: LCTX scores 33/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $5.50 (+428.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, LCTX is in a strong downtrend. The price is approaching resistance at $1.04. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: LCTX scores 33/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $5.50 (+428.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$0.93 -
$1.01
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
42.1%
All Signals
- BEARISH: Weak technical setup (33/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 428.8% below Wall St target ($5.50)
- WARNING: Composite score 50/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$0.93 -
$1.01
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$0.92
Resistance Level
$1.05
Current Trend
Strong Downtrend
Technical data as of
Oct 28, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-7.56
Wall Street Target
$5.50
(+428.8%)
Revenue Growth (YoY)
-61.3%
Profit Margin
-246.6%
Share & Embed Analysis
Last updated: October 28, 2026 7:19 PM ET
Data refreshes hourly during market hours. Next update: 8:19 PM
Data refreshes hourly during market hours. Next update: 8:19 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is LCTX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical âĻ |
STRONG BUY
28 analysts |
$92 | 64 BUY |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
22 analysts |
$280 | 51 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
23 analysts |
$108 | 46 HOLD |
|
WVE
Wave Life Sciences Ltd |
STRONG BUY
21 analysts |
$18 | 49 HOLD |
|
INCY
Incyte Corporation |
HOLD
28 analysts |
$130 | 57 HOLD |
